Impact of high-flow oxygen therapy during exercise in idiopathic pulmonary fibrosis: a pilot crossover clinical trial

[Background] Supplemental oxygen delivered with standard oxygen therapy (SOT) improves exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). Although high-flow nasal cannula oxygen therapy (HFNC) improves oxygenation in other respiratory diseases, its impact on exercise performance...

Descripción completa

Detalles Bibliográficos
Autores: Badenes-Bonet, Diana, Cejudo, Pilar, Rodó-Pin, Anna, Martín-Ontiyuelo, Clara, Chalela, Roberto, Rodríguez-Portal, José A., Vázquez-Sánchez, Rosa, Gea, Joaquim, Duran, Xavier, Caguana, Oswaldo Antonio, Rodríguez-Chiaradía, Diego, A., Balcells Vilarnau, Eva
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/269526
Acceso en línea:http://hdl.handle.net/10261/269526
Access Level:acceso abierto
Palabra clave:Idiopathic pulmonary fibrosis
High‑flow nasal cannula
Oxygen therapy
Exertional desaturation
Descripción
Sumario:[Background] Supplemental oxygen delivered with standard oxygen therapy (SOT) improves exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). Although high-flow nasal cannula oxygen therapy (HFNC) improves oxygenation in other respiratory diseases, its impact on exercise performance has never been evaluated in IPF patients. We hypothesized that HFNC may improve exercise capacity in IPF subjects compared to SOT.

Similares en LA Referencia